DK1286674T3 - Sammensætning til forstærkning af cancerkemoterapeutiske midler - Google Patents

Sammensætning til forstærkning af cancerkemoterapeutiske midler

Info

Publication number: DK1286674T3
Authority: DK; Denmark
Prior art keywords: chemotherapeutic agents; composition; cancer chemotherapeutic; enhancing cancer; enhancing
Prior art date: 2000-09-01

Application number

DK01964398T

Other languages

Danish (da)

English (en)

Inventor

Raxit J Jariwalla

Original Assignee

Ester C Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-01

Filing date

2001-08-24

Publication date

2008-11-03

2001-08-24 Application filed by Ester C Company filed Critical Ester C Company

2008-11-03 Application granted granted Critical

2008-11-03 Publication of DK1286674T3 publication Critical patent/DK1286674T3/da

Links

239000002246 antineoplastic agent Substances 0.000 title abstract 2
230000002708 enhancing effect Effects 0.000 title 1
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 1
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
CIWBSHSKHKDKBQ-JLAZNSOCSA-M L-ascorbate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CIWBSHSKHKDKBQ-JLAZNSOCSA-M 0.000 abstract 1
150000000994 L-ascorbates Chemical class 0.000 abstract 1
229930003268 Vitamin C Natural products 0.000 abstract 1
235000010323 ascorbic acid Nutrition 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
150000002241 furanones Chemical class 0.000 abstract 1
229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
239000011707 mineral Substances 0.000 abstract 1
235000019154 vitamin C Nutrition 0.000 abstract 1
239000011718 vitamin C Substances 0.000 abstract 1
150000003700 vitamin C derivatives Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK01964398T 2000-09-01 2001-08-24 Sammensætning til forstærkning af cancerkemoterapeutiske midler DK1286674T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/654,377 US6468980B1 (en)	2000-09-01	2000-09-01	Methods and compositions for potentiating cancer chemotherapeutic agents
PCT/US2001/026455 WO2002020023A1 (en)	2000-09-01	2001-08-24	Methods and compositions for potentiating cancer chemotherapeutic agents

Publications (1)

Publication Number	Publication Date
DK1286674T3 true DK1286674T3 (da)	2008-11-03

Family

ID=24624611

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01964398T DK1286674T3 (da)	2000-09-01	2001-08-24	Sammensætning til forstærkning af cancerkemoterapeutiske midler

Country Status (15)

Country	Link
US (1)	US6468980B1 (de)
EP (1)	EP1286674B1 (de)
JP (1)	JP2004508335A (de)
KR (1)	KR20030019297A (de)
AT (1)	ATE400267T1 (de)
AU (1)	AU8525401A (de)
CA (1)	CA2389602A1 (de)
CY (1)	CY1108787T1 (de)
DE (1)	DE60134740D1 (de)
DK (1)	DK1286674T3 (de)
ES (1)	ES2309085T3 (de)
MX (1)	MXPA02004327A (de)
PT (1)	PT1286674E (de)
TR (1)	TR200201192T1 (de)
WO (1)	WO2002020023A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6878744B2 (en) *	1999-02-05	2005-04-12	Oxycal Laboratories, Inc.	Vitamin C compositions
CN1197561C (zh) *	2001-07-03	2005-04-20	北京巨能亚太生命科学研究中心	L－苏糖酸钙在制备预防或治疗损及软骨的疾病的药物中的用途
AU2003269967A1 (en)	2003-08-13	2005-03-10	Oxycal Laborataries, Inc.	Methods for the amelioration of environmental oxidant stress and the regulation of beneficial genes
EP3542785A1 (de) *	2007-01-31	2019-09-25	Rutgers, The State University of New Jersey	Gesteuerte freisetzung von wirkstoffen in der haut
KR101998246B1 (ko) *	2018-08-22	2019-07-10	주식회사 메타파인즈	금속이온에 결합된 이온화합물을 포함하는 암 치료용 약학 조성물
TR2022000209A2 (tr)	2022-01-07	2022-02-21	Oezge Gueven	Ozoni̇ze c-vi̇tami̇ni̇ i̇çeren bi̇r anti̇-kanser i̇laci

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6846687A (en) *	1985-12-05	1987-06-30	American Biotechnology Co. Ltd.	Anthracycline type antitumor agents with l-ascorbic acid
GB8810173D0 (en) *	1988-04-29	1988-06-02	Norsk Hydro As	Pharmaceutical compositions with anti-cancer activity & method for treatment of cancer
WO1990012571A1 (en) *	1989-04-07	1990-11-01	Oxycal Laboratories, Inc.	Compositions and methods for administering vitamin c
JPH08291075A (ja) *	1995-04-20	1996-11-05	Showa Denko Kk	癌転移阻害剤
EP0875246A1 (de) *	1997-04-04	1998-11-04	Showa Denko Kabushiki Kaisha	Pharmazeutische Zusammensetzung aus Ascorbinsäurederivate zur Behandlung von Krebs
KR100636991B1 (ko) *	1998-02-06	2006-10-23	질라 뉴트라수티컬즈, 인코포레이티드	안정한 액체 미네랄 아스코르베이트 조성물, 이를 제조하는 방법 및 이를 사용하는 방법
US20040092549A1 (en) *	1999-08-30	2004-05-13	Jariwalla Raxit J	Methods and compositions for selective cancer chemotherapy

2000
- 2000-09-01 US US09/654,377 patent/US6468980B1/en not_active Expired - Lifetime
2001
- 2001-08-24 DK DK01964398T patent/DK1286674T3/da active
- 2001-08-24 EP EP01964398A patent/EP1286674B1/de not_active Expired - Lifetime
- 2001-08-24 KR KR1020027005605A patent/KR20030019297A/ko not_active Ceased
- 2001-08-24 AT AT01964398T patent/ATE400267T1/de not_active IP Right Cessation
- 2001-08-24 DE DE60134740T patent/DE60134740D1/de not_active Expired - Lifetime
- 2001-08-24 MX MXPA02004327A patent/MXPA02004327A/es active IP Right Grant
- 2001-08-24 WO PCT/US2001/026455 patent/WO2002020023A1/en not_active Ceased
- 2001-08-24 CA CA002389602A patent/CA2389602A1/en not_active Abandoned
- 2001-08-24 PT PT01964398T patent/PT1286674E/pt unknown
- 2001-08-24 TR TR2002/01192T patent/TR200201192T1/xx unknown
- 2001-08-24 JP JP2002524507A patent/JP2004508335A/ja active Pending
- 2001-08-24 AU AU85254/01A patent/AU8525401A/en not_active Abandoned
- 2001-08-24 ES ES01964398T patent/ES2309085T3/es not_active Expired - Lifetime
2008
- 2008-09-23 CY CY20081101028T patent/CY1108787T1/el unknown

Also Published As

Publication number	Publication date
WO2002020023A1 (en)	2002-03-14
PT1286674E (pt)	2008-08-21
ES2309085T3 (es)	2008-12-16
EP1286674A4 (de)	2005-12-21
DE60134740D1 (de)	2008-08-21
ATE400267T1 (de)	2008-07-15
US6468980B1 (en)	2002-10-22
CY1108787T1 (el)	2014-04-09
AU8525401A (en)	2002-03-22
CA2389602A1 (en)	2002-03-14
EP1286674B1 (de)	2008-07-09
EP1286674A1 (de)	2003-03-05
MXPA02004327A (es)	2002-11-07
TR200201192T1 (tr)	2003-05-21
KR20030019297A (ko)	2003-03-06
JP2004508335A (ja)	2004-03-18

Publication	Publication Date	Title
TR200000782T2 (tr)	2000-09-21	Resorsinol türevleri.
DE60106954D1 (de)	2004-12-09	Resorcin-derivate
ES2184149T3 (es)	2003-04-01	Paclitaxeles 6-tio sustituidos.
ATE387435T1 (de)	2008-03-15	Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren
MXPA04004347A (es)	2004-08-11	Nuevos fotoindicadores difuncionales.
BR0209149A (pt)	2004-07-13	Ftalazinonas
HRP20030154B1 (en)	2009-03-31	Preparation of risperidone
CY1108787T1 (el)	2014-04-09	Συνθεση για ενισχυση χημειοθεραπευτικων παραγοντων καρκινου
TR200100455T2 (tr)	2001-07-23	Nimesulid içeren topikal farmasötik bileşimler
DE60005031D1 (de)	2003-10-09	Partikel mit kontrollierter freisetzungsrate
TR200102742T2 (tr)	2002-05-21	Rezorsinol türevleri
SE9903290D0 (sv)	1999-09-15	Novel compounds
DE60316128D1 (de)	2007-10-18	N-sulfonylurea-apoptosis-förderer
BG105964A (en)	2002-08-30	C(10) carbonate substituted taxanes and their use as antitumor agents
ATE232081T1 (de)	2003-02-15	Orale zusammensetzung enthaltend perlit
TR200302193T4 (tr)	2004-02-23	Kombinasyon kemoterapisi.
DK1177191T3 (da)	2004-04-05	Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
DE60134814D1 (de)	2008-08-28	C10-carbamoyloxysubstituierte taxane als antitumormittel
DE60133600D1 (de)	2008-05-29	C7-carbamoyloxysubstituierte taxane als antitumormittel
BR0113202A (pt)	2003-07-01	Compostos de trioxepano
DK1521752T3 (da)	2009-06-22	Makrocykliske forbindelser til behandling af cancer
ATE250340T1 (de)	2003-10-15	7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
DE60220699D1 (de)	2007-07-26	Tibolonformulierungen
DE60213522D1 (de)	2006-09-14	Kombination von Arnica, Ruscus und Menthol
UA33865A (uk)	2001-02-15	Дикалієва сіль n-сукцин - dl-триптофану, що має антиангінальну та антигіпоксантну дію